T
Tatsuya Yoshida
Researcher at Nagoya City University
Publications - 103
Citations - 1555
Tatsuya Yoshida is an academic researcher from Nagoya City University. The author has contributed to research in topics: Lung cancer & Cancer. The author has an hindex of 17, co-authored 84 publications receiving 1011 citations.
Papers
More filters
Journal ArticleDOI
Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer
Tatsuya Yoshida,Yuko Oya,Kosuke Tanaka,Junichi Shimizu,Yoshitsugu Horio,Hiroaki Kuroda,Yukinori Sakao,Toyoaki Hida,Yasushi Yatabe +8 more
TL;DR: The most frequent ALK variant was variant 1 in 19 patients (54%), followed by variant 2 in five patients (14%), variant 3a/3b in four patients (12%), and other variants in seven patients (20%) as discussed by the authors.
Journal ArticleDOI
Re-biopsy status among non-small cell lung cancer patients in Japan: A retrospective study
Kaname Nosaki,Miyako Satouchi,Takayasu Kurata,Tatsuya Yoshida,Isamu Okamoto,Nobuyuki Katakami,Fumio Imamura,Kaoru Tanaka,Yuki Yamane,Nobuyuki Yamamoto,Terufumi Kato,Katsuyuki Kiura,Hideo Saka,Hiroshige Yoshioka,Kana Watanabe,Keiko Mizuno,Takashi Seto +16 more
TL;DR: This study sheds light on the re-biopsy status after disease progression in patients with advanced or metastatic NSCLC, and is important to improve the selection of patients who may benefit from third-generation TKIs.
Journal ArticleDOI
Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation
Tatsuya Yoshida,Genichiro Ishii,Koichi Goto,Shinya Neri,Hiroko Hashimoto,Kiyotaka Yoh,Seiji Niho,Shigeki Umemura,Shingo Matsumoto,Hironobu Ohmatsu,Shinsuke Iida,Akio Niimi,Kanji Nagai,Yuichiro Ohe,Atsushi Ochiai +14 more
TL;DR: Podoplanin-positive CAFs play an important role in primary resistance to EGFR-TKIs and may be an ideal therapeutic target for use in combination therapy with EGFR to TKIs.
Journal ArticleDOI
Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer.
Yuko Oya,Tatsuya Yoshida,Hiroaki Kuroda,Masashi Mikubo,Chiaki Kondo,Junichi Shimizu,Yoshitsugu Horio,Yukinori Sakao,Toyoaki Hida,Yasushi Yatabe +9 more
TL;DR: Clinical parameters, such as PS, serum CRP, serum LDH, and smoking status, were significantly associated with the response duration and survival in patients treated with nivolumab.
Journal ArticleDOI
Protective Effect of Magnesium Preloading on Cisplatin-induced Nephrotoxicity: A Retrospective Study
Tatsuya Yoshida,Seiji Niho,Mayuko Toda,Koichi Goto,Kiyotaka Yoh,Shigeki Umemura,Shingo Matsumoto,Hironobu Ohmatsu,Yuichiro Ohe +8 more
TL;DR: It is indicated that magnesium preloading before cisplatin administration significantly reduced cisPlatin-induced nephrotoxicity.